Myobloc®(Botulinum Toxin Type B) Injectable Solution from Solstice Neurosciences, Inc.

  • Myobloc®(Botulinum Toxin Type B) Injectable Solution

Description

Myobloc (Botulinum Toxin Type B) Injectable Solution, the only Botulinum Toxin Type B treatment available, has been demonstrated in numerous published studies to be safe and effective in treating cervical dystonia.

Delivered as a purified, ready-to-use solution, in three convenient vial sizes, Myobloc offers a simpler way to significantly reduce abnormal head position and neck pain associated with cervical dystonia.

  • Product Specs
  • ItemMyobloc®(Botulinum Toxin Type B) Injectable Solution
  • CompanySolstice Neurosciences, Inc.
  • Price Inquire
  • ApprovalUS FDA
  • Product NumberInquire
  • StorageStore under refrigeration at 2°- 8°C (36°- 46°F).
  • IndicationsMYOBLOC® is indicated for the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.
  • Mechanism of ActionInquire
  • PackagingMYOBLOC® is provided as a clear and colorless to light yellow sterile injectable solution in single use 3.5-mL glass vials. Each single use vial of formulated
    MYOBLOC® contains 5000 Ua of Botulinum Toxin Type B per milliliter in 0.05% human serum albumin, 0.01M sodium succinate, 0.1 M sodium chloride at approximately pH 5.6.
  • Units/Vial2,500 units in 0.5 mL
    5,000 units in 1.0 mL
    10,000 units in 2.0 mL
  • Suggested ReconstitutionInquire
Add to Compare List